AI assistant
CytomX Therapeutics, Inc. — Director's Dealing 2017
May 18, 2017
32770_dirs_2017-05-18_b5f4e513-9737-4587-9eea-1643103a6de4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CytomX Therapeutics, Inc. (CTMX)
CIK: 0001501989
Period of Report: 2017-05-15
Reporting Person: RAY DEBANJAN (Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 21928 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.1339 | 2021-09-13 | Common Stock (34485) | Direct | |
| Stock Option (Right to Buy) | $1.2599 | 2023-12-10 | Common Stock (33225) | Direct | |
| Stock Option (Right to Buy) | $1.4489 | 2024-02-27 | Common Stock (19510) | Direct | |
| Stock Option (Right to Buy) | $4.4728 | 2025-05-06 | Common Stock (30640) | Direct | |
| Stock Option (Right to Buy) | $6.6147 | 2025-07-20 | Common Stock (85938) | Direct | |
| Stock Option (Right to Buy) | $6.6147 | 2025-08-25 | Common Stock (41090) | Direct | |
| Stock Option (Right to Buy) | $14.46 | 2026-01-20 | Common Stock (45000) | Direct | |
| Stock Option (Right to Buy) | $11.94 | 2027-01-24 | Common Stock (97500) | Direct | |
| Stock Option (Right to Buy) | $14.62 | 2027-05-12 | Common Stock (30000) | Direct |
Footnotes
F1: 100% of the shares subject to the option are fully vested and exercisable.
F2: This option vests in 48 substantially equal monthly installments starting on July 31, 2013, with each additional installment vesting on the last day of each month thereafter, subject to the Reporting Person's continued service to the Issuer through each such date.
F3: This option vests in 48 substantially equal monthly installments starting on February 28, 2014, with each additional installment vesting on the last day of each month thereafter, subject to the Reporting Person's continued service to the Issuer through each such date.
F4: This option vests in 48 substantially equal monthly installments starting on January 31, 2015, with each additional installment vesting on the last day of each month thereafter, subject to the Reporting Person's continued service to the Issuer through each such date.
F5: This option vests in 48 substantially equal monthly installments starting on July 1, 2015, with each additional installment vesting on the last day of each month thereafter, subject to the Reporting Person's continued service to the Issuer through each such date.
F6: This option vests in 48 substantially equal monthly installments starting on August 28, 2015, with each additional installment vesting on the last day of each month thereafter, subject to the Reporting Person's continued service to the Issuer through each such date.
F7: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2016 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.
F8: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2017 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.
F9: This option vests in 48 substantially equal monthly installments starting on May 15, 2017, subject to the Reporting Person's continued service to the Issuer through each such date.